These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 29775702)

  • 1. Abnormal Sleep Architecture and Hippocampal Circuit Dysfunction in a Mouse Model of Fragile X Syndrome.
    Boone CE; Davoudi H; Harrold JB; Foster DJ
    Neuroscience; 2018 Aug; 384():275-289. PubMed ID: 29775702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal hippocampal theta and gamma hypersynchrony produces network and spike timing disturbances in the Fmr1-KO mouse model of Fragile X syndrome.
    Arbab T; Battaglia FP; Pennartz CMA; Bosman CA
    Neurobiol Dis; 2018 Jun; 114():65-73. PubMed ID: 29486296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kv7/M channel dysfunction produces hyperexcitability in hippocampal CA1 pyramidal cells of Fmr1 knockout mice.
    Luque MA; Morcuende S; Torres B; Herrero L
    J Physiol; 2024 Aug; 602(15):3769-3791. PubMed ID: 38976504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinase-9 deletion rescues auditory evoked potential habituation deficit in a mouse model of Fragile X Syndrome.
    Lovelace JW; Wen TH; Reinhard S; Hsu MS; Sidhu H; Ethell IM; Binder DK; Razak KA
    Neurobiol Dis; 2016 May; 89():126-35. PubMed ID: 26850918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Voltage-Independent SK-Channel Dysfunction Causes Neuronal Hyperexcitability in the Hippocampus of
    Deng PY; Carlin D; Oh YM; Myrick LK; Warren ST; Cavalli V; Klyachko VA
    J Neurosci; 2019 Jan; 39(1):28-43. PubMed ID: 30389838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired hippocampal representation of place in the Fmr1-knockout mouse model of fragile X syndrome.
    Arbab T; Pennartz CMA; Battaglia FP
    Sci Rep; 2018 Jun; 8(1):8889. PubMed ID: 29892074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excitability is increased in hippocampal CA1 pyramidal cells of Fmr1 knockout mice.
    Luque MA; Beltran-Matas P; Marin MC; Torres B; Herrero L
    PLoS One; 2017; 12(9):e0185067. PubMed ID: 28931075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic reduction of MMP-9 in the Fmr1 KO mouse partially rescues prepulse inhibition of acoustic startle response.
    Kokash J; Alderson EM; Reinhard SM; Crawford CA; Binder DK; Ethell IM; Razak KA
    Brain Res; 2019 Sep; 1719():24-29. PubMed ID: 31128097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fragile X mental retardation protein replacement restores hippocampal synaptic function in a mouse model of fragile X syndrome.
    Zeier Z; Kumar A; Bodhinathan K; Feller JA; Foster TC; Bloom DC
    Gene Ther; 2009 Sep; 16(9):1122-9. PubMed ID: 19571888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal development of auditory responses in the inferior colliculus of a mouse model of Fragile X Syndrome.
    Nguyen AO; Binder DK; Ethell IM; Razak KA
    J Neurophysiol; 2020 Jun; 123(6):2101-2121. PubMed ID: 32319849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GABAB receptor-mediated feed-forward circuit dysfunction in the mouse model of fragile X syndrome.
    Wahlstrom-Helgren S; Klyachko VA
    J Physiol; 2015 Nov; 593(22):5009-24. PubMed ID: 26282581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in CA1 hippocampal synapses in a mouse model of fragile X syndrome.
    Jawaid S; Kidd GJ; Wang J; Swetlik C; Dutta R; Trapp BD
    Glia; 2018 Apr; 66(4):789-800. PubMed ID: 29274095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gamma power abnormalities in a Fmr1-targeted transgenic rat model of fragile X syndrome.
    Kozono N; Okamura A; Honda S; Matsumoto M; Mihara T
    Sci Rep; 2020 Nov; 10(1):18799. PubMed ID: 33139785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experience-dependent changes in hippocampal spatial activity and hippocampal circuit function are disrupted in a rat model of Fragile X Syndrome.
    Asiminas A; Booker SA; Dando OR; Kozic Z; Arkell D; Inkpen FH; Sumera A; Akyel I; Kind PC; Wood ER
    Mol Autism; 2022 Dec; 13(1):49. PubMed ID: 36536454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translation-relevant EEG phenotypes in a mouse model of Fragile X Syndrome.
    Lovelace JW; Ethell IM; Binder DK; Razak KA
    Neurobiol Dis; 2018 Jul; 115():39-48. PubMed ID: 29605426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Audiogenic Seizures in the
    Gonzalez D; Tomasek M; Hays S; Sridhar V; Ammanuel S; Chang CW; Pawlowski K; Huber KM; Gibson JR
    J Neurosci; 2019 Dec; 39(49):9852-9863. PubMed ID: 31666356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal CA1 Place Fields but Discoordinated Network Discharge in a Fmr1-Null Mouse Model of Fragile X Syndrome.
    Talbot ZN; Sparks FT; Dvorak D; Curran BM; Alarcon JM; Fenton AA
    Neuron; 2018 Feb; 97(3):684-697.e4. PubMed ID: 29358017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Taurine regulation of short term synaptic plasticity in fragile X mice.
    El Idrissi A; Neuwirth LS; L'Amoreaux W
    J Biomed Sci; 2010 Aug; 17 Suppl 1(Suppl 1):S15. PubMed ID: 20804589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperexcitability in the Olfactory Bulb and Impaired Fine Odor Discrimination in the
    Kuruppath P; Xue L; Pouille F; Jones ST; Schoppa NE
    J Neurosci; 2023 Nov; 43(48):8243-8258. PubMed ID: 37788940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of Phosphodiesterase 2A Activity in the Pathophysiology of Fragile X Syndrome.
    Maurin T; Melancia F; Jarjat M; Castro L; Costa L; Delhaye S; Khayachi A; Castagnola S; Mota E; Di Giorgio A; Servadio M; Drozd M; Poupon G; Schiavi S; Sardone L; Azoulay S; Ciranna L; Martin S; Vincent P; Trezza V; Bardoni B
    Cereb Cortex; 2019 Jul; 29(8):3241-3252. PubMed ID: 30137253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.